PLOS ONE retracts breast cancer genetics paper after claim of misappropriated data

PLOS ONE has retracted a 2012 article by a group of breast cancer researchers after another scientist — a leading U.S. oncologist — objected that the data came from his lab. The paper, “GREB1 Functions as a Growth Promoter and Is Modulated by IL6/STAT3 in Breast Cancer,” came from a team composed of researchers at … Continue reading PLOS ONE retracts breast cancer genetics paper after claim of misappropriated data

PLoS ONE issues expression of concern when company won’t share bacterial strain

The editors of PLoS ONE have issued an expression of concern for a 2014 article on a form of nitrogen-fixing bacteria called Bacillus pumilus. The reason: The company that provided the strain of microbe used in the research won’t let other researchers look at the organism. The article is titled “Bacillus pumilus Reveals a Remarkably … Continue reading PLoS ONE issues expression of concern when company won’t share bacterial strain

Three PLOS ONE papers retracted for totally made-up data

This one comes to us from Twitter, where Willem van Schaik went to express his frustration that a PLOS ONE paper he’d edited had been retracted for fake data. Two other papers from the same group at the Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Chandigarh, India, were retracted simultaneously. We sent van Schaik … Continue reading Three PLOS ONE papers retracted for totally made-up data

Wayward “contractor” prompts expression of concern for PLoS ONE paper on cancer cells

The editors of PLoS ONE have issued an Expression of Concern (which seems likely to become a retraction) for a 2014 paper by a group of researchers in China who claim to have been led astray by a contractor hired to “edit the language” of the report. The article, “Arsenic Sulfide Promotes Apoptosis in Retinoid … Continue reading Wayward “contractor” prompts expression of concern for PLoS ONE paper on cancer cells

Chutzpah: Authors blame PLOS ONE for failing to find plagiarism in paper on Botulinum toxin

Holy Chutzpah, Batman! A team of researchers in India has retracted their 2012 paper in PLoS One on botulinum toxin for plagiarism — while blaming the journal for failing to use its “soft wares” to catch the plagiarism. The article, “Small-Molecule Quinolinol Inhibitor Identified Provides Protection against BoNT/A in Mice,” was written by a group … Continue reading Chutzpah: Authors blame PLOS ONE for failing to find plagiarism in paper on Botulinum toxin

Tenth retraction appears for Jesús Lemus, this one in PLOS ONE

Just two days ago, we covered the ninth retraction for Jesús Lemus, “the veterinary researcher whose work colleagues have had trouble verifying, including being unable to confirm the identity of one of his co-authors.” And already another of his retractions has appeared in one of our daily alerts. This one appears in PLOS ONE, for … Continue reading Tenth retraction appears for Jesús Lemus, this one in PLOS ONE

Cossu-UCL follow-up: PLOS ONE paper to be corrected

We have a follow-up from last week’s story about a University College London (UCL) investigation into the work of Giulio Cossu that found errors but no “deliberate intention to mislead.”UCL said it will not make the full report available:

Orangutan-Ebola link in PLOS ONE paper under scrutiny

PLOS ONE has issued a fascinating expression of concern about data collection in a paper it published late last year on the possible spread of deadly viruses among Indonesian orangutans. The case has been brought to the attention of the Indonesian government, but more on that in a moment. The article, published last July by … Continue reading Orangutan-Ebola link in PLOS ONE paper under scrutiny

“Unreliable” findings fell TB gene study in PLOS ONE

Here’s a nice example of how science should work. A team of Swiss microbiologists has retracted their 2012 paper in PLoS One on the genetics of the TB mycobacterium after learning that the fusion protein they thought they’d used in their study was in fact a different molecule. Here’s the retraction notice for the article, … Continue reading “Unreliable” findings fell TB gene study in PLOS ONE

Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction

A new study in Clinical Chemistry paints an alarming picture of how often scientists deposit data that they’re supposed to — but perhaps not surprisingly, papers whose authors did submit such data scored higher on a quality scale than those whose authors didn’t deposit their data. Ken Witwer, a pathobiologist at Hopkins, was concerned that … Continue reading Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction